|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Cholesterol and coronary heart disease mortality显示文摘 | Sleight P | 1992 | Astr New Zealand J Med1992，22，： | 1 |
| 2 | Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study显示文摘 | Sleight P Redon J Verdecchia P | 2009 | J Hypertens2009，27，： | 1 |
| 3 | Short acting dihydropyridine (vasodilating) calcium channel blockers for hypertension: is there a risk? 显示文摘 | Beevers DG Sleight P | 1996 | BMJ1996，312，： | 1 |
| 4 | The importance of the autonomic nervous system in hearth and disease显示文摘 | Sleight P | 1997 | Aust N Z J Med1997，27，4： | 1 |
| 5 | Comparative effects of ramipril on ambulatory and office blood pressures显示文摘 | Svensson P de Faire U Sleight P | 2001 | Hypertension2001，38，6： | 1 |
| 6 | Enhanced negative thermal expansion in Lu2W3O12 显示文摘 | Forster P M Yokoehi A Sleight AW | 1998 | J Solid State Chem1998，140，： | 1 |
| 7 | The HOPE Study: Heart Outcomes Prevention Evaluation显示文摘 | Sleight P | 2000 | Renin Angiotensin Aldosterone Syst2000，1，1： | 1 |
| 8 | Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by angiotension - converting enzyme inhibitor ramipril 显示文摘 | Mathew J Sleight P Lonn E | 2001 | Circulation2001，104，： | 1 |
| 9 | Rationale, design, and baseline characteristics of a large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients:the ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE intolerant subjects with cardiovascular disease ( ONTARGET/TRANSCEND)triaI显示文摘 | Teo K Yusuf S Sleight P | 2004 | Am Heart J2004，148，： | 1 |
| 10 | Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study显示文摘 | Sleight P Redon J Verdecchia P | 2009 | J Hypertens2009，27，7： | 1 |
| 11 | Heart Outcomes Prevention E-valuation(HOPE)Investigatom Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramJipril显示文摘 | Matthew J Sleight P Lonn E | | 0，，08： | 1 |
| 12 | Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Tehnisartan Random- ized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRAN- SCEND) trials显示文摘 | TEO K YUSUF S SLEIGHT P | 2004 | Am Heart J2004，148，： | 1 |
| 13 | Enhanced negative thermal expansion in Lu2WaO12显示文摘 | FORSTER P M YOKOCHI A SLEIGHT A W | 1998 | Journal of Solid State Chemistry1998，140，1： | 1 |
| 14 | Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by angiotension converting enzyme inhibition ramipril 显示文摘 | Mathew J Sleight P Lonn E | 2001 | Circulation2001，104，14： | 1 |
| 15 | Negative thermal expan- sion in Y2WaO12显示文摘 | FORSTER P M SLEIGHT A W | 1999 | International Journal of Inorganic Ma- terials1999，1，2： | 1 |
| 16 | Diminished baroreflex sensitivity in high blood pressure显示文摘 | Bristow JD Honour AJ Picketing GW Sleight P Smyth HS | 1969 | Circulation1969，39，1： | 1 |
| 17 | High-temperature superconductivity in BaPb1-x Bix O3 system 显示文摘 | Sleight A W Gilson J L Bierstedt P E | 1975 | Solid State Commun1975，17，1： | 1 |
| 18 | Association between hemodynamic im- pairment and Cheyne-Stokes respiration and periodic breathing in chronic stable congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopa- thy显示文摘 | Mortara A Sleight P Pinna GD | 1999 | Am J Cardiol1999，84，8： | 1 |
| 19 | Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET ( ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial ) 显示文摘 | Redon J Mancia G Sleight P | 2012 | J Am Coil Cardiol2012，59，1： | 1 |
| 20 | QT interval dynamics and heart rate variability preceding acue of ca rd-e arrest显示文摘 | Singh JP Sleight P Kardos A | 2006 | Heart2006，77，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员